Literature DB >> 4608311

Thymidine-dependent Escherichia coli infection and some associated laboratory problems.

E I Tanner, C H Bullin.   

Abstract

The rapid emergence of a thymidine-dependent strain of Escherichia coli in a patient treated with co-trimoxazole is described. The organism was recovered from blood cultures during a septicaemia which developed after only a few days of co-trimoxazole treatment. The cultural characteristics of three thymidine-dependent strains were studied and a remarkable variation was found in their ability to grow on different batches of blood agar, depending upon the age of the plates and the type of agar base used.

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4608311      PMCID： PMC475397          DOI： 10.1136/jcp.27.7.565

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  5 in total

1.  Joint trimethoprim and sulphamethoxazole resistance in bacteria infected with R factors.

Authors:  R J Pinney; J T Smith
Journal:  J Med Microbiol       Date:  1973-02       Impact factor: 2.472

2.  Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients.

Authors:  J Barker; D Healing; J G Hutchison
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

3.  Thymine-requiring mutants of Proteus mirabilis selected by co-trimoxazole in vivo.

Authors:  O A Okubadejo; R M Maskell
Journal:  J Gen Microbiol       Date:  1973-08

4.  Sensitivity testing with trimethorpim-sulphamethoxazole.

Authors:  S R Bushby
Journal:  Med J Aust       Date:  1973-06-30       Impact factor: 7.738

5.  Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media.

Authors:  A E Koch; J J Burchall
Journal:  Appl Microbiol       Date:  1971-11
  5 in total
  6 in total

1.  Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs.

Authors:  Johannes Zander; Silke Besier; Hanns Ackermann; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

2.  In Vitro Time-Kill Studies of Trimethoprim/Sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli Using Cation-Adjusted Mueller-Hinton Broth and ISO-Sensitest Broth.

Authors:  Maxwell J Lasko; Matthew L Gethers; Jennifer L Tabor-Rennie; David P Nicolau; Joseph L Kuti
Journal:  Antimicrob Agents Chemother       Date:  2022-01-10       Impact factor: 5.938

3.  Catalase-negative Escherichia coli isolated from blood.

Authors:  H Funada; K I Hattori; N Kosakai
Journal:  J Clin Microbiol       Date:  1978-05       Impact factor: 5.948

4.  Infection caused by thymidine-requiring, trimethoprim-resistant bacteria.

Authors:  C H King; D M Shlaes; M J Dul
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

5.  In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus.

Authors:  Indranil Chatterjee; Andre Kriegeskorte; Andreas Fischer; Susanne Deiwick; Nadine Theimann; Richard A Proctor; Georg Peters; Mathias Herrmann; Barbara C Kahl
Journal:  J Bacteriol       Date:  2007-09-28       Impact factor: 3.490

6.  Inactivation of thyA in Staphylococcus aureus attenuates virulence and has a strong impact on metabolism and virulence gene expression.

Authors:  Andre Kriegeskorte; Desiree Block; Mike Drescher; Nadine Windmüller; Alexander Mellmann; Cathrin Baum; Claudia Neumann; Nicola Ivan Lorè; Alessandra Bragonzi; Eva Liebau; Patrick Hertel; Jochen Seggewiss; Karsten Becker; Richard A Proctor; Georg Peters; Barbara C Kahl
Journal:  MBio       Date:  2014-07-29       Impact factor: 7.867
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.